Christine Granfield

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Douglas E. Onsi, as attorney-in-fact for Christine Granfield
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christine Granfield:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LEAP THERAPEUTICS, INC. VP, Head of Reg Affairs/Qual Common Stock 15.9K $5.03K $0.32 Mar 28, 2025 Direct
LEAP THERAPEUTICS, INC. VP, Head of Reg Affairs/Qual Restricted Stock Units 0 $0 $0.32 Mar 28, 2025 Direct
LEAP THERAPEUTICS, INC. VP, Head of Reg Affairs/Qual Employee Stock Option (Right to Buy) 85K Oct 2, 2024 Direct

Insider Reports Filed by Christine Granfield

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LPTX LEAP THERAPEUTICS, INC. Mar 28, 2025 3 -$2.09K 4 Apr 1, 2025 VP, Head of Reg Affairs/Qual
LPTX LEAP THERAPEUTICS, INC. Oct 2, 2024 1 $0 4 Oct 4, 2024 VP, Head of Reg Affairs/Qual
LPTX LEAP THERAPEUTICS, INC. Jan 29, 2024 1 $0 4 Jan 31, 2024 VP, Head of Reg Affairs/Qual
LPTX LEAP THERAPEUTICS, INC. Aug 23, 2023 1 $0 4 Aug 25, 2023 VP, Head of Reg Affairs/Qual
LPTX LEAP THERAPEUTICS, INC. Mar 31, 2023 1 $0 4 Apr 4, 2023 VP, Head of Reg Affairs/Qual
LPTX LEAP THERAPEUTICS, INC. Sep 1, 2022 1 $0 4 Sep 2, 2022 VP, Head of Reg Affairs/Qual
LPTX LEAP THERAPEUTICS, INC. Jan 31, 2022 1 $0 4 Feb 2, 2022 VP, Head of Reg Affairs/Qual
LPTX LEAP THERAPEUTICS, INC. May 26, 2021 1 $0 4 May 28, 2021 VP, Head of Reg Affairs/Qual